| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Silvio Buffa | |
| Giovanni Ruvolo | |||
| Domenico Lio | |||
| Calogera Pisano | |||
| Giuseppe Mazzesi | |||
| Carmela R Balistreri | |||
| P2860 | cites work | Endothelial progenitor cells: what use for the cardiologist? | Q21198698 |
| Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities. | Q21202035 | ||
| Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association | Q22241921 | ||
| Cardiac stem cells: biology and clinical applications | Q26825051 | ||
| Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) | Q28216990 | ||
| Endothelial progenitor cells in cardiovascular disorders | Q28288695 | ||
| Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
| Endothelial progenitors | Q28303877 | ||
| Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association | Q30080021 | ||
| Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans | Q31113632 | ||
| Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results | Q31970825 | ||
| Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial | Q33151955 | ||
| Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions | Q33181601 | ||
| Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats. | Q33237964 | ||
| EPC mobilization after erythropoietin treatment in acute ST-elevation myocardial infarction: the REVEAL EPC substudy | Q33558915 | ||
| Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy | Q33919886 | ||
| Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function | Q33941111 | ||
| Endothelial progenitor cells in cardiovascular diseases | Q34038864 | ||
| Endothelial progenitor cells as putative targets for angiostatin | Q73292244 | ||
| Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial | Q74811727 | ||
| Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay | Q80665054 | ||
| Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy | Q81790396 | ||
| Mediterranean diet reduces endothelial damage and improves the regenerative capacity of endothelium | Q82695925 | ||
| Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia | Q82862777 | ||
| Time-dependent dynamic mobilization of circulating progenitor cells during percutaneous coronary intervention in diabetics | Q83212303 | ||
| Combining stem cells and tissue engineering in cardiovascular repair -- a step forward to derivation of novel implants with enhanced function and self-renewal characteristics | Q83331369 | ||
| The expression of functional Toll-like receptor 4 is associated with proliferation and maintenance of stem cell phenotype in endothelial progenitor cells (EPCs) | Q84310809 | ||
| Population aging, the dependency burden, and challenges facing preventive medicine | Q84788300 | ||
| Circulating endothelial progenitor cells, vascular function, and cardiovascular risk | Q39513285 | ||
| Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation | Q40611732 | ||
| Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha | Q42031332 | ||
| The endothelium, a protagonist in the pathophysiology of critical illness: focus on cellular markers | Q42146414 | ||
| Decreased number of circulating endothelial progenitor cells in patients with Graves' hyperthyroidism. | Q42473520 | ||
| Endothelial progenitor cells in subclinical hypothyroidism: the effect of thyroid hormone replacement therapy | Q43246221 | ||
| Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure | Q44411377 | ||
| Circulating endothelial progenitor cells during human pregnancy | Q45178368 | ||
| Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model | Q45865348 | ||
| Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia | Q46458517 | ||
| Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study | Q46693648 | ||
| Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens | Q46752443 | ||
| Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization | Q47998965 | ||
| Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. | Q51618016 | ||
| Moderate-to-high-intensity training and a hypocaloric Mediterranean diet enhance endothelial progenitor cells and fitness in subjects with the metabolic syndrome. | Q54518388 | ||
| Molecular evaluation of endothelial progenitor cells in patients with ischemic limbs: therapeutic effect by stem cell transplantation. | Q54697304 | ||
| Bone marrow stem cells regenerate infarcted myocardium | Q35072264 | ||
| Transplantation of endothelial progenitor cells for therapeutic neovascularization. | Q35218990 | ||
| Endothelial progenitor cells enter the aging arena | Q35765879 | ||
| Endothelial progenitor cells functional characterization | Q35982242 | ||
| Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. | Q35985560 | ||
| The intersection between aging and cardiovascular disease | Q36006533 | ||
| Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy? | Q36328639 | ||
| Endothelial progenitor cell dysfunction in cardiovascular diseases: role of reactive oxygen species and inflammation | Q36665257 | ||
| Frontiers in nephrology: the evolving therapeutic applications of endothelial progenitor cells | Q36974148 | ||
| Endothelium in health and disease | Q37085324 | ||
| Hypoxia inducible factor-1 alpha, endothelial progenitor cells, monocytes, cardiovascular risk, wound healing, cobalt and hydralazine: a unifying hypothesis | Q37160712 | ||
| A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood | Q37201827 | ||
| The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential | Q37348530 | ||
| Potential use of endothelial progenitor cells for regeneration of the vasculature | Q37368684 | ||
| Cardiac cell repair therapy: a clinical perspective | Q37371934 | ||
| Endothelial progenitor cells - hype or hope? | Q37389638 | ||
| Endothelium and its alterations in cardiovascular diseases: life style intervention | Q37639902 | ||
| Endothelial progenitor cells: hope beyond controversy | Q37780768 | ||
| Pluripotent stem cell differentiation into vascular cells: A novel technology with promises for vascular re(generation) | Q37802009 | ||
| Mobilization of stem and progenitor cells in cardiovascular diseases | Q37905521 | ||
| Endothelial progenitor cells: current issues on characterization and challenging clinical applications | Q37957761 | ||
| Atherosclerosis, inflammation, genetics, and stem cells: 2012 update | Q38000082 | ||
| Contribution of endothelial progenitor cells to neovascularization (Review). | Q38038030 | ||
| Quantification of circulating CD34+/KDR+/CD45dim endothelial progenitor cells: analytical considerations. | Q38061513 | ||
| Effect of aging on metabolic pathways in endothelial progenitor cells | Q38061654 | ||
| Current status of NADPH oxidase research in cardiovascular pharmacology | Q38132120 | ||
| Natural history of mesenchymal stem cells, from vessel walls to culture vessels. | Q38155429 | ||
| Concise review: the surface markers and identity of human mesenchymal stem cells | Q38191872 | ||
| Emerging treatment options for refractory angina pectoris: ranolazine, shock wave treatment, and cell-based therapies | Q38206882 | ||
| Cardiovascular prevention: lifestyle and statins--competitors or companions? | Q38217644 | ||
| Endothelial progenitor cells and cardiovascular disease | Q38243386 | ||
| Endothelial progenitor cells and revascularization following stroke. | Q38366059 | ||
| Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications | Q38413376 | ||
| Circulating endothelial progenitor cells: Do they live up to their name? | Q38419242 | ||
| Effects of shear stress on endothelial progenitor cells. | Q38493323 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell | Q7868 |
| cardiovascular disease | Q389735 | ||
| stem cell transplantation | Q65592366 | ||
| bone marrow cells | Q66004840 | ||
| P304 | page(s) | 835934 | |
| P577 | publication date | 2015-10-05 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | Are Endothelial Progenitor Cells the Real Solution for Cardiovascular Diseases? Focus on Controversies and Perspectives | |
| P478 | volume | 2015 |
| Q51474863 | Abnormal correlation of circulating endothelial progenitor cells and endothelin-1 concentration may contribute to the development of arterial hypertension in childhood acute lymphoblastic leukemia survivors. |
| Q51759669 | Anti-Inflamm-Ageing and/or Anti-Age-Related Disease Emerging Treatments: A Historical Alchemy or Revolutionary Effective Procedures? |
| Q58740797 | Deregulation of Notch1 pathway and circulating endothelial progenitor cell (EPC) number in patients with bicuspid aortic valve with and without ascending aorta aneurysm |
| Q26744129 | Electrical muscle stimulation in thomboprophylaxis: review and a derived hypothesis about thrombogenesis-the 4th factor |
| Q89038320 | Endothelial progenitor cells in age-related vascular remodeling |
| Q91130350 | Expansion of Human Pluripotent Stem Cell-derived Early Cardiovascular Progenitor Cells by a Cocktail of Signaling Factors |
| Q64885976 | MHY2233 Attenuates Replicative Cellular Senescence in Human Endothelial Progenitor Cells via SIRT1 Signaling. |
| Q37340099 | MicroRNA-195 regulates proliferation, migration, angiogenesis and autophagy of endothelial progenitor cells by targeting GABARAPL1 |
| Q52352341 | Shear stress: An essential driver of endothelial progenitor cells. |
| Q90020213 | Stem cell therapy: old challenges and new solutions |
| Q47192672 | Surface functionalization of electrospun scaffolds using recombinant human decorin attracts circulating endothelial progenitor cells |
| Q38438419 | The Protein Content of Extracellular Vesicles Derived from Expanded Human Umbilical Cord Blood-Derived CD133+ and Human Bone Marrow-Derived Mesenchymal Stem Cells Partially Explains Why both Sources are Advantageous for Regenerative Medicine |
| Q39019418 | The bone marrow pericyte: an orchestrator of vascular niche |
| Q90541377 | Tips for success in pulmonary hypertension treatment: progress in isolating endothelial cells from pulmonary artery catheters |
Search more.